The PRP hair growth timeline is the conversation that decides whether a patient completes the protocol, and most clinicians run it backwards. They promise growth, the patient looks for growth, and at the six-week mark — long before growth is physically possible — the patient concludes the treatment has failed and quietly stops booking.
The fix is not better reassurance. It is teaching the patient the right thing to look for, in the right order, at the right time. That requires you to be fluent in the cycle physiology yourself, because the honest answer to "when will I see something?" is not a single date. It is three different signals arriving on three different schedules, only one of which is visible in a mirror.
Tatiana Sarmiento sets up the whole conversation with one instruction she gives every hair patient, and it is the most useful sentence in this article: "Pay attention to your pillow. If you see less hair, that's actually the PRP responding."
Start with the physiology, because the timeline is derived from it
Scalp hair grows at roughly 0.35 mm per day — on the order of one centimetre a month, or a little more. That rate is essentially fixed. It is not the variable PRP acts on, and no biologic meaningfully accelerates it.
Which means the growth rate is not why month one is empty. Do the arithmetic and a centimetre a month should be visible. The reason month one shows nothing is entirely different, and once you understand it you can explain it in thirty seconds at the chair.
Scalp follicles cycle asynchronously through three phases:
Anagen — active growth. On the scalp this phase runs for years, commonly two to six, and it is what determines how long a hair can get before it is shed. At any moment the large majority of scalp follicles are in anagen.
Catagen — a short regression phase of a couple of weeks, in which the lower follicle involutes.
Telogen — rest. On the scalp this lasts roughly three months. The shaft sits in the follicle, no longer growing, anchored and waiting. At the end of telogen it is released and shed, and the follicle re-enters anagen to produce a new one.
Two consequences follow, and both of them structure the timeline.
First: a follicle you stimulate today does not produce visible hair today. If the target follicle is in telogen — and the follicles you most want to recruit are — it has to complete or exit that phase, re-enter anagen, and build a new shaft from the base. That shaft then has to traverse the length of the follicular canal before a single millimetre of it clears the scalp surface. The growth rate is normal throughout. The delay is structural, not sluggish.
Second: the hair the patient sheds is not the hair PRP is growing. The shaft leaving the pillow is the terminal event of a cycle that began months ago. Shedding reflects what a follicle decided in the recent past. Growth reflects what it is doing now. They are two different clocks, and patients conflate them constantly.
Androgenetic miniaturisation adds a third mechanism. In pattern loss, successive cycles run with a progressively shorter anagen phase and a progressively finer shaft. Shorter anagen means the hair is shed before it ever reaches the length it used to reach, which is why miniaturising areas look thin even where follicles are still present. This matters for counselling because it defines the ceiling: the therapeutic goal in androgenetic alopecia is to lengthen anagen and recover shaft calibre in follicles that still exist. It is not to create follicles that do not. That ceiling is a property of the biology rather than of the product, which is why it applies equally across the regenerative options a patient may have read about — see the exosomes versus PDRN versus PRP comparison for where those differ and where they do not.
Month one: nothing is visible, and that is the expected finding
Say this out loud at the consultation, before the first treatment, not at the month-one visit as damage control.
At four weeks, no follicle recruited by the first session has produced hair that clears the scalp. It is physically too early. Any patient who reports visible improvement at week four is reporting something else — a good hair day, better lighting, a haircut, the placebo effect that attends any attentive clinical encounter, or genuine changes in scalp condition that are not hair.
What can be present at month one:
- Scalp comfort and condition changes. Some patients report reduced itch or scale. This is not the endpoint and should not be sold as one.
- A shed that has not changed, or has increased. Patients starting any follicular stimulation may notice a transient rise in shedding as resting follicles are released synchronously before new growth begins. This is well described with topical pharmacotherapy; with PRP the pattern is reported clinically rather than well characterised in trial data. Mention it as a possibility, framed as neutral, so that if it happens the patient does not interpret it as harm.
- Nothing at all, which is the common and correct result.
The counselling script at month one is therefore not "be patient." It is specific: "Nothing should be visible yet and nothing is. The follicle has to finish a cycle before it can show us anything. What I want you watching between now and next month is not your hairline — it's how much hair is on your pillow and in the drain."
That redirection is the single highest-value thing you do at the month-one visit. It moves the patient's attention from a variable that cannot change yet to one that can.
The first honest signal is reduced shedding, not visible growth
This is the reframe that holds a protocol together, and it is physiologically defensible.
Normal scalp shedding runs on the order of tens of hairs a day — commonly quoted as up to about a hundred, with wide individual variation. In active pattern loss, and in effluvium states, that figure rises. If treatment stabilises follicles that were heading into premature telogen, the first measurable consequence is fewer hairs leaving, and that consequence can appear well before any new shaft is long enough to see.
It is also the only outcome variable the patient can measure themselves, daily, at no cost — which is exactly why Tatiana hands it to them: "Early shedding changes may be noticeable. The patient can still see hair on the pillow. I always mention it — pay attention to your pillow."
Make it structured rather than impressionistic:
- Give the patient a specific, repeatable observation. The pillow in the morning, or the hair collected from the shower drain after a wash, counted or photographed against a plain contrasting surface. Same observation, same conditions, same frequency.
- Ask them to note it weekly, not daily. Daily counts amplify normal variation into anxiety.
- Warn them explicitly that wash frequency changes the count. A patient who washes every third day sheds three days' worth into that drain. Comparing a post-wash count to a non-wash-day count generates a fake signal in either direction.
- Record what they report in the chart alongside your own objective measurements, and treat it as supporting data rather than as the endpoint.
The clinical honesty requirement attaches here. Reduced shedding is a legitimate early signal. It is not proof of regrowth, it is not guaranteed, and it should never be presented as the result the patient is paying for. It is the first thing to watch while the slower variables develop.
Month three: the first reassessment that means anything
Three months is not an arbitrary follow-up interval. It approximates the duration of telogen, which makes it the earliest point at which follicles recruited around the start of the protocol can have produced an emergent, measurable shaft.
Tatiana schedules exactly here. Her protocol runs three to four monthly sessions and then, in her words, "we reassess three months later." And on what the patient should expect: they "should expect to see some hair growing by month number three."
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Functional & Regenerative Medicine courses — live patients, expert faculty, and ongoing mentorship.
What to look for at the three-month assessment, in order of reliability:
Shaft calibre on trichoscopy. The most informative early finding. Recovering follicles produce thicker shafts over the same scalp area, and calibre contributes more to perceived thickness than count does. A narrowing of shaft-diameter variability within your fixed target field is a meaningful signal.
Short, emergent, fine new hairs. Visible at magnification along the hairline and within the treated field. These are real, they are countable, and a patient who has had the physiology explained will find them convincing when you show them on screen.
Target-area counts. Compare against baseline in the same fixed window with the same scale reference. The methodology for this — the capture standard, the relocation method, terminal and vellus counts — is covered in the measurement piece in this cluster, and it is what makes the three-month conversation evidence-led rather than a mutual guess.
Global photography. Least sensitive at this stage. Useful as part of the series; rarely dramatic at three months. Do not lead with it.
The decision made at this visit is not "did it work." It is whether the trajectory justifies continuing as planned, adding sessions, or revisiting the diagnosis. Tatiana's framing of the cadence is explicitly individual: "Some patients need more treatments — six instead of three. That is an assessment you have to do." That is a scheduling judgement based on observed response, and it is made with the measurements in front of you.
Month six: where coverage becomes the subject
Six months is where global photography starts to earn its place, and where the patient's own perception may finally begin to agree with your data.
By this point, follicles recruited early in the protocol have had time to produce shafts of several centimetres — long enough to lie down, integrate with surrounding hair and contribute to coverage rather than standing up as visible stubble. Density changes in the fixed target area are more likely to be measurable. Calibre gains that were marginal at three months have had two further monthly sessions layered on top.
What still will not have happened at six months, and must have been said at month zero:
- Recession of a mature receded hairline where the follicles are gone rather than miniaturised. PRP acts on follicles that exist.
- Scarring alopecia reversal. Follicular destruction is not reversible, which is why the workup precedes the treatment.
- A density result comparable to surgical restoration. Different intervention, different endpoint.
The month-six visit is also the natural moment to reset the horizon, because a patient who believes they have arrived at an endpoint will stop — and stopping is what undoes the result. Tatiana is direct with patients about this from the start: "I mention to my patient that this is a treatment you need to repeat every year, because you want to keep giving the growth factor to that follicle." The structural and behavioural side of that — why patients disappear and how to build a service that keeps them — is the subject of the maintenance piece in this cluster.
The script, compressed
Said at consultation, before the first session, in roughly this order:
"Hair grows about a centimetre a month, and that rate doesn't change. What we're trying to change is how many of your follicles are actively growing and how thick the hair they produce is. A follicle that's resting has to restart, build a new hair from the base, and push it up the canal before you see anything at all. That's why month one will look like nothing happened — it should.
The first thing that changes is usually how much hair you lose, not how much you grow. Watch your pillow and your shower drain, once a week, same conditions. Less hair leaving is the early sign.
At three months I'll re-photograph and re-measure, and that's when we make a real decision. At six months we should be talking about coverage. And this is an ongoing treatment, not a course — we'll be planning maintenance, not a finish line."
Four sentences of physiology buy you a patient who knows what they are looking at, and a patient who knows what they are looking at is a patient who completes the protocol.
These protocols and intervals reflect Tatiana Sarmiento's clinical practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.
Clinicians who want the diagnostic, preparation and injection sides of this protocol trained together can find them in Empire's medical hair loss, PDO thread and PRP hair restoration training; the preparation fundamentals sit in platelet rich plasma training.
Frequently Asked Questions
When do PRP hair patients actually see results?
Nothing is visible at one month, because a stimulated follicle must re-enter growth and push a new shaft up the follicular canal before any of it clears the scalp. Emergent fine hairs and calibre changes are typically assessable around three months; coverage changes become the subject around six. Reduced shedding may be noticeable earlier.
Why does hair shedding sometimes increase after starting PRP?
Resting follicles released synchronously back into growth shed the old shaft first, which can transiently raise the visible count before new hair appears. The pattern is well described with topical pharmacotherapy and reported clinically with PRP. Counsel it as a possibility in advance so that it is not misread as the treatment causing loss.
How fast does scalp hair grow?
Roughly 0.35 mm per day, which works out to about one centimetre a month. That rate is broadly fixed and is not what platelet-rich plasma acts on. The therapeutic targets in pattern loss are the duration of the growth phase and the calibre of the shaft, not the speed of elongation.
Is reduced shedding proof that PRP is working?
It is a legitimate early signal, not proof. Shedding reflects follicular decisions made weeks to months earlier and varies with wash frequency, season and stress. Treat a patient-reported reduction as supporting evidence alongside standardised photography and target-area counts, and never present it as the outcome being purchased.
What should be assessed at the three-month PRP reassessment?
Shaft calibre and diameter variability on trichoscopy, emergent fine hairs within the treated field, terminal and vellus counts in the fixed target area against baseline, and the standardised photographic series. The decision is whether the trajectory justifies continuing, extending the series, or revisiting the diagnosis — not a pass-or-fail verdict.
Disclaimer
This article reflects the clinical opinions and experience of Tatiana Sarmiento, Empire Medical Training faculty, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.
It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.
